Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the ...

Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by billions ...

Medicare coverage of weight loss drugs, if authorized, is seen increasing federal spending by about $35B from 2026 to 2034.

Investors in weight-loss drug companies like Novo Nordisk and Eli Lilly face concerns over side effects and market ...

According to the Congressional Budget Office, the average 2034 per-user effect could be $650 in savings and $4,300 in costs ...

Medicare is prohibited by law from covering GLP-1 drugs for weight loss. But many beneficiaries can access the drugs anyway.

The Centers for Medicare and Medicaid Services (CMS) just shared a preliminary list of generic drugs it plans to make ...

Covering anti-obesity drugs in the US Medicare program would increase federal spending by about $35 billion over nine years, ...

The average workplace health insurance plan costs more than $25,000 amid rising prices and expensive weight-loss drugs such as Wegovy.

Federal officials have spent the past few days scrambling to move one factory’s inventory of IV fluid out of Florida as a ...

Good evening. As Hurricane Milton barrels toward the west coast of Florida ahead of an expected landfall tonight, the ...